CARGO Therapeutics (CRGX) News Today $4.17 +0.13 (+3.22%) Closing price 04:00 PM EasternExtended Trading$4.17 0.00 (0.00%) As of 06:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Is CARGO Therapeutics (NASDAQ:CRGX) In A Good Position To Deliver On Growth Plans?March 27 at 12:04 PM | finance.yahoo.comCargo suspends CRG-023 and allogeneic platform, reduces workforce by 90%March 20, 2025 | markets.businessinsider.comCARGO Therapeutics Stock (NASDAQ:CRGX) Jumps 20% on Buyout HopesMarch 19, 2025 | markets.businessinsider.comCargo Therapeutics, Inc.: CARGO Therapeutics Provides Corporate UpdateMarch 19, 2025 | finanznachrichten.deCargo Therapeutics Ceases More Treatment Development, Cuts 90% of JobsMarch 18, 2025 | marketwatch.comCARGO Therapeutics rises after hours on workforce reductionMarch 18, 2025 | msn.comCARGO Therapeutics Provides Corporate UpdateMarch 18, 2025 | globenewswire.comCARGO Therapeutics (CRGX) Projected to Post Earnings on ThursdayMarch 18, 2025 | americanbankingnews.comQ1 EPS Forecast for CARGO Therapeutics Decreased by AnalystMarch 18, 2025 | americanbankingnews.comBrokerages Set CARGO Therapeutics, Inc. (NASDAQ:CRGX) PT at $15.00March 18, 2025 | americanbankingnews.comWilliam Blair Expects Weaker Earnings for CARGO TherapeuticsCARGO Therapeutics, Inc. (NASDAQ:CRGX - Free Report) - Equities research analysts at William Blair lowered their Q1 2025 earnings estimates for shares of CARGO Therapeutics in a report released on Thursday, March 13th. William Blair analyst S. Corwin now forecasts that the company will post earniMarch 17, 2025 | marketbeat.comCARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives Consensus Recommendation of "Reduce" from AnalystsShares of CARGO Therapeutics, Inc. (NASDAQ:CRGX - Get Free Report) have earned a consensus rating of "Reduce" from the seven research firms that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and six have asMarch 15, 2025 | marketbeat.comCARGO Therapeutics, Inc.: Hold Rating Amidst Developmental Stagnation and Future ProspectsMarch 13, 2025 | tipranks.comCARGO Therapeutics (CRGX) to Release Quarterly Earnings on ThursdayCARGO Therapeutics (NASDAQ:CRGX) will be releasing earnings before the market opens on Thursday, March 20, Financial Modeling Prep reports.March 13, 2025 | marketbeat.comCARGO Therapeutics: A Gutted CAR T Player Trying To Find New DirectionMarch 3, 2025 | seekingalpha.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CARGO Therapeutics, Inc - CRGXFebruary 25, 2025 | prnewswire.comCARGO Therapeutics Highlights Progress in CAR T TherapyFebruary 24, 2025 | tipranks.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CARGO Therapeutics, Inc - CRGXFebruary 18, 2025 | prnewswire.comCARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives Consensus Recommendation of "Reduce" from BrokeragesShares of CARGO Therapeutics, Inc. (NASDAQ:CRGX - Get Free Report) have earned a consensus recommendation of "Reduce" from the seven analysts that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation and six have given a hoFebruary 18, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CARGO Therapeutics, Inc - CRGXFebruary 11, 2025 | prnewswire.comCRGX Investors Have Opportunity to Join CARGO Therapeutics, Inc. Securities Fraud Investigation with the Schall Law FirmFebruary 6, 2025 | prnewswire.comCARGO Therapeutics, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - CRGXFebruary 5, 2025 | markets.businessinsider.comHC Wainwright Expects Higher Earnings for CARGO TherapeuticsCARGO Therapeutics, Inc. (NASDAQ:CRGX - Free Report) - Equities research analysts at HC Wainwright boosted their Q1 2025 earnings estimates for shares of CARGO Therapeutics in a report issued on Thursday, January 30th. HC Wainwright analyst R. Burns now anticipates that the company will earn ($0.February 3, 2025 | marketbeat.comWilliam Blair Has Optimistic Outlook of CRGX Q1 EarningsCARGO Therapeutics, Inc. (NASDAQ:CRGX - Free Report) - Investment analysts at William Blair boosted their Q1 2025 earnings per share (EPS) estimates for shares of CARGO Therapeutics in a research note issued on Thursday, January 30th. William Blair analyst S. Corwin now anticipates that the compaFebruary 3, 2025 | marketbeat.comWilliam Blair Downgrades CARGO Therapeutics (CRGX)February 1, 2025 | msn.comTruist cuts Cargo Therapeutics rating, slashes PT to $7January 31, 2025 | msn.comCARGO Therapeutics (NASDAQ:CRGX) Reaches New 12-Month Low - Should You Sell?CARGO Therapeutics (NASDAQ:CRGX) Sets New 12-Month Low - Should You Sell?January 31, 2025 | marketbeat.comPeninsula biotech moves from IPO to chopping half its workforce in little more than a yearJanuary 31, 2025 | bizjournals.comTruist Securities Downgrades CARGO Therapeutics (CRGX)January 31, 2025 | msn.comCRGX Investors Have Opportunity to Join CARGO Therapeutics, Inc. Securities Fraud Investigation with the Schall Law FirmJanuary 30, 2025 | prnewswire.comCARGO Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - CRGXJanuary 30, 2025 | prnewswire.comCARGO Therapeutics (NASDAQ:CRGX) Lowered to "Neutral" Rating by HC WainwrightHC Wainwright cut CARGO Therapeutics from a "buy" rating to a "neutral" rating in a research report on Thursday.January 30, 2025 | marketbeat.comCARGO Therapeutics (NASDAQ:CRGX) Downgraded by Truist Financial to "Hold"Truist Financial downgraded CARGO Therapeutics from a "buy" rating to a "hold" rating and lowered their price objective for the company from $32.00 to $7.00 in a research note on Thursday.January 30, 2025 | marketbeat.comCARGO Therapeutics (NASDAQ:CRGX) Lowered to Underweight Rating by JPMorgan Chase & Co.JPMorgan Chase & Co. lowered shares of CARGO Therapeutics from an "overweight" rating to an "underweight" rating in a research report on Thursday.January 30, 2025 | marketbeat.comCARGO Therapeutics (NASDAQ:CRGX) Downgraded to "Market Perform" Rating by William BlairWilliam Blair cut CARGO Therapeutics from an "outperform" rating to a "market perform" rating in a research note on Thursday.January 30, 2025 | marketbeat.comCARGO Therapeutics (NASDAQ:CRGX) Downgraded to "Neutral" Rating by Piper SandlerPiper Sandler cut CARGO Therapeutics from an "overweight" rating to a "neutral" rating and reduced their price target for the stock from $34.00 to $4.00 in a report on Thursday.January 30, 2025 | marketbeat.comCARGO Therapeutics (NASDAQ:CRGX) Downgraded by Jefferies Financial Group to HoldJefferies Financial Group lowered shares of CARGO Therapeutics from a "buy" rating to a "hold" rating and decreased their target price for the stock from $32.00 to $3.00 in a research report on Thursday.January 30, 2025 | marketbeat.comCARGO Therapeutics (NASDAQ:CRGX) Stock Rating Lowered by Chardan CapitalChardan Capital cut shares of CARGO Therapeutics from a "buy" rating to a "neutral" rating in a research note on Thursday.January 30, 2025 | marketbeat.comCARGO Therapeutics, Inc. (CRGX) was downgraded to a Hold Rating at William BlairJanuary 30, 2025 | markets.businessinsider.comCargo Therapeutics stock tumbles after trial setbackJanuary 30, 2025 | au.investing.comCargo Therapeutics stock rating cut by Jefferies to HoldJanuary 30, 2025 | msn.comJPMorgan cuts Cargo Therapeutics stock rating to UnderweightJanuary 30, 2025 | msn.comCARGO Therapeutics, Inc. (CRGX) was downgraded to a Hold Rating at JefferiesJanuary 30, 2025 | markets.businessinsider.comCargo Therapeutics to Lay Off 50% of Workers, Stop Developing Blood Cancer TreatmentJanuary 29, 2025 | marketwatch.comCargo Therapeutics to discontinue FIRCE-1 Phase 2 study of Firi-celJanuary 29, 2025 | markets.businessinsider.comCARGO halts Phase 2 study of cancer treatmentJanuary 29, 2025 | msn.comCRGX Investors Have Opportunity to Join CARGO Therapeutics, Inc. Securities Fraud Investigation with the Schall Law FirmJanuary 29, 2025 | businesswire.comCARGO Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - CRGXJanuary 29, 2025 | businesswire.comCARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic OptionsJanuary 29, 2025 | globenewswire.comCARGO Therapeutics, Inc. (NASDAQ:CRGX) Given Consensus Recommendation of "Buy" by BrokeragesShares of CARGO Therapeutics, Inc. (NASDAQ:CRGX - Get Free Report) have received an average rating of "Buy" from the six research firms that are presently covering the firm, MarketBeat reports. Six investment analysts have rated the stock with a buy recommendation. The average 1 year price objectiJanuary 24, 2025 | marketbeat.com Remove Ads Get CARGO Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRGX and its competitors with MarketBeat's FREE daily newsletter. Email Address CRGX Media Mentions By Week CRGX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRGX News Sentiment▼0.040.78▲Average Medical News Sentiment CRGX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRGX Articles This Week▼33▲CRGX Articles Average Week Remove Ads Get CARGO Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRGX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ABCL News Today PRTA News Today BCAX News Today CRON News Today IMNM News Today NUVB News Today MLYS News Today AVBP News Today BCYC News Today CVAC News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRGX) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CARGO Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CARGO Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.